- Home
- Find medicine
- Human medicines
This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).
The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level.
Use this search to find information including a public-friendly overview in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.
As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency’s decision-making. For more information see clinical data publication.
The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.
More information is available on the Central authorisation procedure and in EPARs: background and context.

Name | Active substance | Therapeutic area | Date of authorisation / refusal | Additional monitoring | Orphan | Has current safety alert | Status | ||
---|---|---|---|---|---|---|---|---|---|
Axumin |
fluciclovine (18F) |
Prostatic Neoplasms Radionuclide Imaging | 2017-05-22 | Authorised | |||||
Docetaxel Accord |
docetaxel |
Adenocarcinoma Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms | 2012-05-22 | Authorised | |||||
Docetaxel Kabi |
docetaxel |
Adenocarcinoma Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms | 2012-05-22 | Authorised | |||||
Docetaxel Teva |
docetaxel |
Adenocarcinoma Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms Stomach Neoplasms | 2010-01-26 | Authorised | |||||
Docetaxel Winthrop |
docetaxel |
Adenocarcinoma Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms Stomach Neoplasms | 2007-04-20 | Authorised | |||||
Firmagon |
degarelix |
Prostatic Neoplasms | 2009-02-17 | Authorised | |||||
Jevtana |
cabazitaxel |
Prostatic Neoplasms | 2011-03-17 | Authorised | |||||
Prolia |
denosumab |
Bone Resorption Osteoporosis, Postmenopausal | 2010-05-26 | Authorised | |||||
Taxespira (previously Docetaxel Hospira UK Limited ) |
docetaxel trihydrate |
Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms Stomach Neoplasms | 2015-08-28 | Authorised | |||||
Taxotere |
docetaxel |
Adenocarcinoma Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Prostatic Neoplasms Stomach Neoplasms | 1995-11-27 | Authorised | |||||
Xofigo |
radium Ra223 dichloride |
Prostatic Neoplasms | 2013-11-13 | Authorised | |||||
Xtandi |
enzalutamide |
Prostatic Neoplasms | 2013-06-21 | Authorised | |||||
Zytiga |
abiraterone acetate |
Prostatic Neoplasms | 2011-09-05 | Authorised |